A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy

James O'Doherty

doi:10.17229/jdit.2015-0428-016

A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy

James O'Doherty

PET Imaging Centre Facility

Research output: Contribution to journal › Article › peer-review

Abstract

Yttrium-90 radioembolization (90Y-RE) is a well-established therapy for the treatment of hepatocellular carcinoma (HCC) and also of metastatic liver deposits from other malignancies. Nuclear Medicine and Cath Lab diagnostic imaging takes a pivotal role in the success of the treatment, and in order to fully exploit the efficacy of the technique and provide reliable quantitative dosimetry that are related to clinical endpoints in the era of personalized medicine, technical challenges in imaging need to be overcome. In this paper, the extensive literature on current 90Y-RE techniques and challenges facing it in terms of quantification and dosimetry are reviewed, with a focus on the current generation of 3D dosimetry techniques. Finally, new emerging techniques are reviewed which seek to overcome these challenges, such as high-resolution imaging, novel surgical procedures and the use of other radiopharmaceuticals for therapy and pre-therapeutic planning.

Original language	English
Number of pages	34
Journal	Journal of Diagnostic Imaging in Therapy
Volume	2
Issue number	2
DOIs	https://doi.org/10.17229/jdit.2015-0428-016
Publication status	Published - 28 Apr 2015

Access to Document

10.17229/jdit.2015-0428-016

Cite this

@article{fcbb4259925048d2a6ebac39c3040529,

title = "A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy",

abstract = "Yttrium-90 radioembolization (90Y-RE) is a well-established therapy for the treatment of hepatocellular carcinoma (HCC) and also of metastatic liver deposits from other malignancies. Nuclear Medicine and Cath Lab diagnostic imaging takes a pivotal role in the success of the treatment, and in order to fully exploit the efficacy of the technique and provide reliable quantitative dosimetry that are related to clinical endpoints in the era of personalized medicine, technical challenges in imaging need to be overcome. In this paper, the extensive literature on current 90Y-RE techniques and challenges facing it in terms of quantification and dosimetry are reviewed, with a focus on the current generation of 3D dosimetry techniques. Finally, new emerging techniques are reviewed which seek to overcome these challenges, such as high-resolution imaging, novel surgical procedures and the use of other radiopharmaceuticals for therapy and pre-therapeutic planning.",

author = "James O'Doherty",

year = "2015",

month = apr,

day = "28",

doi = "10.17229/jdit.2015-0428-016",

language = "English",

volume = "2",

journal = "Journal of Diagnostic Imaging in Therapy",

issn = "2057-3782",

number = "2",

}

TY - JOUR

T1 - A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy

AU - O'Doherty, James

PY - 2015/4/28

Y1 - 2015/4/28

N2 - Yttrium-90 radioembolization (90Y-RE) is a well-established therapy for the treatment of hepatocellular carcinoma (HCC) and also of metastatic liver deposits from other malignancies. Nuclear Medicine and Cath Lab diagnostic imaging takes a pivotal role in the success of the treatment, and in order to fully exploit the efficacy of the technique and provide reliable quantitative dosimetry that are related to clinical endpoints in the era of personalized medicine, technical challenges in imaging need to be overcome. In this paper, the extensive literature on current 90Y-RE techniques and challenges facing it in terms of quantification and dosimetry are reviewed, with a focus on the current generation of 3D dosimetry techniques. Finally, new emerging techniques are reviewed which seek to overcome these challenges, such as high-resolution imaging, novel surgical procedures and the use of other radiopharmaceuticals for therapy and pre-therapeutic planning.

AB - Yttrium-90 radioembolization (90Y-RE) is a well-established therapy for the treatment of hepatocellular carcinoma (HCC) and also of metastatic liver deposits from other malignancies. Nuclear Medicine and Cath Lab diagnostic imaging takes a pivotal role in the success of the treatment, and in order to fully exploit the efficacy of the technique and provide reliable quantitative dosimetry that are related to clinical endpoints in the era of personalized medicine, technical challenges in imaging need to be overcome. In this paper, the extensive literature on current 90Y-RE techniques and challenges facing it in terms of quantification and dosimetry are reviewed, with a focus on the current generation of 3D dosimetry techniques. Finally, new emerging techniques are reviewed which seek to overcome these challenges, such as high-resolution imaging, novel surgical procedures and the use of other radiopharmaceuticals for therapy and pre-therapeutic planning.

U2 - 10.17229/jdit.2015-0428-016

DO - 10.17229/jdit.2015-0428-016

M3 - Article

SN - 2057-3782

VL - 2

JO - Journal of Diagnostic Imaging in Therapy

JF - Journal of Diagnostic Imaging in Therapy

IS - 2

ER -

A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy

Abstract

Access to Document

Fingerprint

Cite this